Verona Pharma PLC PDMR Dealing (3484Y)

TIDMVRP

RNS Number : 3484Y

Verona Pharma PLC

02 March 2017

Verona Pharma plc

PDMR Dealing

 
 1     Details of the person discharging managerial responsibilities/person closely associated 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                     Dr. Jan-Anders Karlsson 
----  -------------------------------------------------------  ------------------------------------------------------- 
 2     Reason for the notification 
----  ---------------------------------------------------------------------------------------------------------------- 
                                                                Chief Executive Officer 
  a)    Position/status 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    Initial notification/Amendment                           Initial notification 
----  -------------------------------------------------------  ------------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, auction platform, auctioneer 
        or auction monitor 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                     Verona Pharma plc 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    LEI                                                      n/a 
----  -------------------------------------------------------  ------------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Description of the financial instrument, type of         Ordinary Shares of 5 pence each 
       instrument                                                GB00BYW2KH80 
       Identification code 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    Nature of the transaction                                Jan-Anders Karlsson purchased 19,750 Ordinary Shares 
----  -------------------------------------------------------  ------------------------------------------------------- 
 c)    Price(s) and volume(s)                                      Price(s)        Volume(s) 
                                                                 --------------  --------------- 
                                                                  149 pence       12,000 
                                                                   per Ordinary    Ordinary 
                                                                   Share           Shares 
                                                                 --------------  --------------- 
                                                                  149 pence       7,750 Ordinary 
                                                                   per Ordinary    Shares 
                                                                   Share 
                                                                 --------------  --------------- 
----  -------------------------------------------------------  ------------------------------------------------------- 
 d)    Aggregated information                                   19,750 Ordinary Shares at 149 pence per Ordinary Share 
        - Aggregated volume 
        - Price 
----  -------------------------------------------------------  ------------------------------------------------------- 
 e)    Date of the transaction                                  12,000 Ordinary Shares on 28 February 2017 and 7,750 
                                                                Ordinary Shares on 1 March 2017 
----  -------------------------------------------------------  ------------------------------------------------------- 
 f)    Place of the transaction                                 London Stock Exchange, AIM 
----  -------------------------------------------------------  -------------------------------------------------------

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEANDAEDFXEEF

(END) Dow Jones Newswires

March 02, 2017 04:36 ET (09:36 GMT)

Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jun 2024 to Jul 2024